Abstract: Among other things, the present disclosure provides oligonucleotides and compositions thereof. In some embodiments, provided oligonucleotides and compositions are useful for adenosine modification. In some embodiments, the present disclosure provides methods for treating various conditions, disorders or diseases that can benefit from adenosine modification.
| # | Name | Date |
|---|---|---|
| 1 | 202317032848-STATEMENT OF UNDERTAKING (FORM 3) [09-05-2023(online)].pdf | 2023-05-09 |
| 2 | 202317032848-POWER OF AUTHORITY [09-05-2023(online)].pdf | 2023-05-09 |
| 3 | 202317032848-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [09-05-2023(online)].pdf | 2023-05-09 |
| 4 | 202317032848-FORM 1 [09-05-2023(online)].pdf | 2023-05-09 |
| 5 | 202317032848-DRAWINGS [09-05-2023(online)].pdf | 2023-05-09 |
| 6 | 202317032848-DECLARATION OF INVENTORSHIP (FORM 5) [09-05-2023(online)].pdf | 2023-05-09 |
| 7 | 202317032848-COMPLETE SPECIFICATION [09-05-2023(online)].pdf | 2023-05-09 |
| 8 | 202317032848.pdf | 2023-05-13 |
| 9 | 202317032848-Proof of Right [15-05-2023(online)].pdf | 2023-05-15 |
| 10 | 202317032848-FORM 3 [07-11-2023(online)].pdf | 2023-11-07 |
| 11 | 202317032848-FORM 18 [06-11-2024(online)].pdf | 2024-11-06 |